Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
about
Performance of rotavirus vaccines in developed and developing countriesRotaviruses: from pathogenesis to vaccinationStructure of Rotavirus Outer-Layer Protein VP7 Bound with a Neutralizing FabHisto-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy.Global impact of rotavirus vaccines.Development of a Bacillus subtilis-based rotavirus vaccineSystems vaccinology.Immunological mechanisms of vaccination.Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countriesDose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.The control of rotavirus gastroenteritis in the United StatesInhibitory effect of breast milk on infectivity of live oral rotavirus vaccines.Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.Correlates of protection induced by vaccination.Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines.Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.Inactivated human rotavirus vaccine induces heterotypic antibody response: correction and development of IgG avidity assay.Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice.Genotyping of human rotaviruses circulating among children with diarrhea in Valencia, Venezuela.Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.
P2860
Q24600612-D0DEA39D-F567-4B11-A394-85E6F7F42477Q24609374-998FAF0B-B90C-43DA-9877-926826DF7051Q27655896-008DF875-384C-487D-A56E-F22988E026F4Q30234848-18DF54C5-1CA2-47F6-B79E-6C8AFF9841E4Q34108591-604ADC02-F4F7-4259-8613-07AA457F0FC3Q34289936-6B71A8F2-D6D7-4ADB-8E6F-9683F79A70D5Q34402910-AF70BE7B-86FF-4EA9-8B24-BEF9DDDB58ADQ35659533-7536AD83-2DC2-43AC-AC4A-EED770E32D4CQ36175693-5F7E0C9D-76E0-423D-9E61-FBD4A717C9D1Q36175711-2C1EF274-A61B-448F-BA51-3F36C56E6639Q36210208-577E9647-5A7B-429B-BFAB-BF525E85D0D9Q36519692-FE5457E2-56EB-4436-90EB-A0C3ED1F80A5Q36992562-FC6A14EA-C40E-4057-B572-B04E84A5138CQ37530047-3846CBDB-7685-4024-ABA3-514CA600AAF1Q37750121-8EDF29AA-33CF-4C48-ACC2-4F2E86A8B9EAQ37981766-D72FB355-392A-4BD0-A16F-B95E0D01B4C1Q38714968-0E4E704A-06BF-43DA-B15C-94C6707FC42BQ38998392-74EA6A89-3C38-48E4-B55B-5FDB447C08B5Q40044140-1D12D846-C762-4808-B26A-E2E339B01C46Q42161902-2862E75E-752F-4B4E-B9CC-D7BE60DC3A8EQ43365960-AB4C6AA6-2D9B-4216-BB36-0ADC3C50320EQ47554106-0075EE80-B015-4C07-819A-CBBFFE3C9C4AQ54343219-9F005244-807E-4921-A1B7-1F5B68BAD3EFQ55405177-D2F25982-FD70-4E21-8779-7499233E0866
P2860
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@en
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@nl
type
label
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@en
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@nl
prefLabel
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@en
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@nl
P2093
P1433
P1476
Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
@en
P2093
Baoming Jiang
Jon R Gentsch
Roger I Glass
P304
P356
10.1016/J.VACCINE.2008.10.008
P407
P577
2008-10-23T00:00:00Z